These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28258535)

  • 1. Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.
    Scichilone N; Braido F; Lavorini F; Levy ML; Usmani OS
    Drugs Aging; 2017 May; 34(5):321-330. PubMed ID: 28258535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
    Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M
    BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
    Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
    Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma maintenance and reliever therapy: Should this be the standard of care?
    Cusack RP; Satia I; O'Byrne PM
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):150-155. PubMed ID: 32339657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Lin J; Li J; Yu W; Liu Y; Liu C; Chen P; He H; He B; Liu S; Zhou X
    Respir Med; 2017 Jun; 127():45-50. PubMed ID: 28502418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis.
    Agarwal R; Khan A; Aggarwal AN; Gupta D
    Monaldi Arch Chest Dis; 2009 Dec; 71(4):161-9. PubMed ID: 20440920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
    Kirsten AM; Watz H; Brindicci C; Piccinno A; Magnussen H
    Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall asthma control: the relationship between current control and future risk.
    Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
    J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination budesonide/formoterol inhaler as sole reliever therapy in Māori and Pacific people with mild and moderate asthma.
    Hardy J; Tewhaiti-Smith J; Baggott C; Fingleton J; Semprini A; Holliday M; Hancox RJ; Weatherall M; Harwood M
    N Z Med J; 2020 Aug; 133(1520):61-72. PubMed ID: 32994594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Hozawa M
    Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.
    Braido F; Baiardini I; Compalati E; Bordo A; Canonica GW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):361-74. PubMed ID: 21659859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide + formoterol fumarate dihydrate for the treatment of asthma.
    Wolthers OD
    Expert Opin Pharmacother; 2016; 17(7):1023-30. PubMed ID: 27070946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.
    Pilcher J; Patel M; Pritchard A; Thayabaran D; Ebmeier S; Shaw D; Black P; Braithwaite I; Weatherall M; Beasley R
    NPJ Prim Care Respir Med; 2017 May; 27(1):33. PubMed ID: 28496190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.